Insider Transactions

BlackRock, Inc. (BLK) Insider Transactions

Over the last 12 months, 27 BlackRock, Inc. (BLK) insiders filed 175 SEC Form 4 transactions — $0 in open-market purchases ( 0 distinct buyers) and $258.8M in open-market sales. 0% of all transactions were executed under a pre-scheduled Rule 10b5-1 trading plan.

Recent Form 4 Filings Most recent 50 of 175 (1-year window)

Each row is a single Form 4 filing event for BLK, sourced directly from SEC EDGAR. The Type column classifies the SEC transaction code into Buy / Sell / Grant / Exercise / Other; the 10b5-1 badge marks trades executed under a pre-scheduled SEC Rule 10b5-1 plan.

Date Insider Title Type SEC Code Value Shares Price
2026-06-01 FINK LAURENCE Chairman and CEO Other G $0 4,780 $0.00
2026-04-28 FINK LAURENCE Chairman and CEO Sell S $10.2M 9,715 $1049.61
2026-04-28 FINK LAURENCE Chairman and CEO Sell S $14.5M 13,834 $1050.44
2026-04-28 FINK LAURENCE Chairman and CEO Sell S $8.6M 8,225 $1051.35
2026-04-28 FINK LAURENCE Chairman and CEO Sell S $2.2M 2,126 $1052.50
2026-04-27 KAPITO ROBERT President Sell S $3.4M 3,188 $1056.10
2026-04-27 KAPITO ROBERT President Sell S $5.7M 5,364 $1056.86
2026-04-27 KAPITO ROBERT President Sell S $197.8K 187 $1057.60
2026-03-31 Vestberg Hans Erik Grant A $0 36 $0.00
2026-03-31 Robbins Charles Grant A $0 30 $0.00
2026-03-31 PECK KRISTIN C Grant A $0 34 $0.00
2026-03-31 Nixon Gordon M. Grant A $0 38 $0.00
2026-03-31 Nasser Amin H. Grant A $0 30 $0.00
2026-03-31 Murphy Kathleen Grant A $0 40 $0.00
2026-03-31 LEMKAU GREGG Grant A $0 29 $0.00
2026-03-31 Johnson Margaret L Grant A $0 37 $0.00
2026-03-31 Freda Fabrizio Grant A $0 21 $0.00
2026-03-31 FORD WILLIAM E Grant A $0 38 $0.00
2026-03-31 Daley Pamela Grant A $0 40 $0.00
2026-02-24 Kushel J. Richard Senior Managing Director Sell $417.7K 385 $1084.91
2026-02-24 Kushel J. Richard Senior Managing Director Sell $2.2M 2,000 $1083.05
2026-02-23 Cohen Stephen Senior Managing Director Sell $240.7K 225 $1069.56
2026-02-19 Cohen Stephen Senior Managing Director Grant $0 657 $0.00
2026-02-13 Goldstein Robert L. Chief Operating Officer Grant $0 8,634 $0.00
2026-02-13 Goldstein Robert L. Chief Operating Officer Grant $0 8,634 $0.00
2026-02-11 Cohen Stephen Senior Managing Director Sell $2.3M 2,179 $1073.87
2026-02-11 Goldstein Robert L. Chief Operating Officer Sell $2.6M 2,364 $1083.11
2026-02-11 Goldstein Robert L. Chief Operating Officer Sell $987.5K 911 $1083.96
2026-02-11 Goldstein Robert L. Chief Operating Officer Sell $518.7K 478 $1085.09
2026-02-11 Goldstein Robert L. Chief Operating Officer Sell $1.7M 1,540 $1085.82
2026-02-10 Goldstein Robert L. Chief Operating Officer Grant $27.8M 54,190 $513.50
2026-02-10 Goldstein Robert L. Chief Operating Officer Grant $0 54,190 $0.00
2026-02-10 Goldstein Robert L. Chief Operating Officer Sell $4.2M 3,839 $1084.06
2026-02-10 Goldstein Robert L. Chief Operating Officer Sell $6.4M 5,924 $1085.10
2026-02-10 Goldstein Robert L. Chief Operating Officer Sell $9.8M 8,992 $1085.97
2026-02-10 Goldstein Robert L. Chief Operating Officer Sell $6.1M 5,608 $1087.05
2026-02-10 Goldstein Robert L. Chief Operating Officer Sell $19.6M 18,046 $1088.00
2026-02-10 Goldstein Robert L. Chief Operating Officer Sell $9.5M 8,708 $1089.00
2026-02-10 Goldstein Robert L. Chief Operating Officer Sell $1.3M 1,215 $1089.93
2026-02-10 Goldstein Robert L. Chief Operating Officer Sell $1.9M 1,740 $1091.34
2026-02-10 Goldstein Robert L. Chief Operating Officer Sell $128.9K 118 $1092.00
2026-02-04 Johnson Margaret L Grant $0 419 $0.00
2026-02-04 Johnson Margaret L Grant $0 419 $0.00
2026-01-31 Comerchero Marc D. Principal Accounting Officer Grant $0 549 $0.00
2026-01-31 Heller Caroline Senior Managing Director Grant $0 627 $0.00
2026-01-31 Meade Christopher J. General Counsel and CLO Grant $0 5,175 $0.00
2026-01-31 Lord Rachel Senior Managing Director Grant $0 6,308 $0.00
2026-01-31 Cohen Stephen Senior Managing Director Grant $0 3,771 $0.00
2026-01-31 Small Martin CFO & Senior Managing Director Grant $0 5,292 $0.00
2026-01-31 Kushel J. Richard Senior Managing Director Grant $0 6,272 $0.00

Showing the most recent 50 of 175 transactions. For the full 1-year history with sorting, filtering, and cross-ticker industry context, open the full insider transactions drilldown.

Methodology & FAQ

How We Track BLK Insider Transactions

Form 4 disclosures are sourced directly from SEC EDGAR and re-ingested on every pipeline cycle. A complete description of transaction-code handling, the open-market vs grant distinction, and the Rule 10b5-1 plan-reference heuristic is documented in the Methodology.

What is an SEC Form 4 filing for BlackRock, Inc.?

Form 4 is a transaction-level disclosure that corporate insiders — officers, directors, and beneficial owners of more than 10% of a registered class of equity securities — must file with the SEC within two business days of any change in their beneficial ownership of BlackRock, Inc. (BLK) shares.

What is a Rule 10b5-1 trading plan?

Rule 10b5-1 is an SEC rule that lets insiders schedule trades in advance under a written plan, providing an affirmative defense against insider-trading allegations as long as the plan was adopted in good faith and not while in possession of material non-public information. Form 4 rows marked "10b5-1" on this page indicate the underlying trade was executed under such a plan; rows without the badge are discretionary or did not reference a plan in the Form 4 footnotes.

How is "insider buying" different from a stock grant or option exercise?

An insider buy (SEC transaction code P) is an open-market purchase of BlackRock, Inc. (BLK) stock executed at the prevailing market price using the insider's personal capital. Stock grants (code A) and option exercises (code M) are compensation events, not directional trades; they are tracked separately and excluded from the "conviction" signal because they are not discretionary purchases.

How recent is the data?

Form 4 transactions are typically reported within two business days of execution. Pactolio re-ingests the EDGAR feed on a nightly cycle and reflects new filings on the next ingest run, typically within 24 hours of EDGAR acceptance. The table on this page covers the most recent 1-year window.